Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Psychiatry
•
Neuromodulation
How do you manage expectations around response time and durability of benefit in patients starting TMS?
Related Questions
Is there a role for administering IV ketamine immediately after ECT treatments in patients with difficult-to-treat major depressive disorder?
At what point do you consider referring for neuromodulatory treatments (TMS, deep brain stimulation) for treatment refractory-OCD?
What is your experience with transcutaneous vagal nerve stimulation for the treatment of anxiety disorders and major depressive disorder?
How do you explain and manage transient post-ECT symptoms like irritability, tearfulness, or panic attacks that resolve within a day?
How do you approach a case of apparent worsening catatonia despite high-dose benzodiazepines and ongoing ECT?
How do you facilitate access to interventional treatments such as TMS for patients with difficult-to-treat depression who are on Medicaid?
When do you refer patients with difficult-to-treat depression for ECT rather than other interventional psychiatric treatments, such as TMS or esketamine?
How have you gone about implementing TMS in your practice or institution?
When do you consider referring adolescents with major depressive disorder for TMS?
Is there a role for leucovorin in improving verbal communication in children with autism spectrum disorder?
